The Oversight Committee issued a subpoena today to Towers Perrin in connection with a Committee inquiry into potential conflicts of interest relating to the advice consultants provide to corporate boards on executive pay.
A letter recently obtained by Chairman Waxman reveals that in 2003, the Justice Department advised Congress that an anti-prostitution pledge requirement in the anti-trafficking bill then under consideration raised "serious First Amendment concerns" and should be struck from the bill. Chairman Waxman reiterates his concerns about the constitutionality and public health effects of this provision in the global AIDS and anti-trafficking LAWS, and asks for a full explanation of DOJ's reversal in opinion.
On Thursday, June 28, the Committee held a hearing entitled “Waste, Fraud, and Abuse at K-Town: How Mismanagement Has Derailed DOD’s Largest Single Facility Construction Project.” The hearing reviewed the preliminary findings of a Government Accountability Office investigation into the construction of the Kaiserslautern Military Community Center, a hotel and retail facility being built on the grounds of the Ramstein Air Base in Germany.
Today, Rep. Henry A. Waxman released a letter he received yesterday afternoon from the Department of Energy regarding the cleanup of the Santa Susana Field Laboratory (SSFL) and the Energy Technology Engineering Center (ETEC). In the letter, the Department agreed to Rep. Waxman’s request to commit to complying with the court order and honor its commitment that a radiological survey be undertaken at the site.
In response to a request by Chairman Waxman, the Department of Energy announced that it would prepare an environmental impact statement prior to the remediation of the Santa Susana Field Laboratory.
In a letter to Attorney General Gonzales, Oversight Chairman Waxman, Judiciary Chairman Conyers, and Oversight Subcommittee Chairman Clay ask for the Justice Department’s view on whether the Office of the Vice President is part of the executive branch and thus bound by the President’s executive order to protect classified information like other White House offices, such as the National Security Council.
Contrary to the recent claims of White House spokesperson Dana Perino, there is evidence that the White House has repeatedly failed to investigate security violations, take corrective action following breaches, and appropriately protect classified information.
Chairman Waxman and Subcommittee Chairman Kucinich have responded to a letter from Samuel Wilson, Deputy Director of the National Institute of Environmental Health Sciences (NIEHS), regarding the new Request for Proposals for the publication of Environmental Health Perspectives.
In letters to Exxon Mobil and Shell Oil, Chairman Waxman asks the companies to voluntarily provide witnesses for a Domestic Policy Subcommittee hearing on temperature-based expansion and contraction of gasoline and the resulting effect on gas prices. Neither company provided a witness for the subcommittee’s first hearing on the issue, and Chairman Waxman writes that he would “like to avoid the necessity to issue a subpoena.”
In a letter to DOE Secretary Bodman, Chairman Waxman asks for clarification of inconsistent statements the Department has made about the cleanup of the Santa Susana Field Laboratory and the Energy Technology and Engineering Center. DOE’s actions and track record suggest the Department may not intend to conduct a court-ordered Environmental Impact Statement before continuing its cleanup activities at the site. Chairman Waxman asks DOE to detail its plan, commit to complying with the court order, and honor its commitment to fund an EPA radiological survey of the site.
On Friday, June 22, the Committee on Oversight and Government Reform held a hearing on the response of the Department of Health and Human Services to the nation’s emergency room crisis.
The Oversight Committee has learned that over the objections of the National Archives, Vice President Cheney exempted his office from the presidential order that establishes government-wide procedures for safeguarding classified national security information. The Vice President asserts that his office is not an “entity within the executive branch.”
In a letter to Council on Environmental Quality Chairman Connaughton, Chairman Waxman and Ranking Member Davis set a firm deadline for the White House to provide climate change documents that were requested eleven months ago. Despite numerous discussions and requests, CEQ has withheld over 500 responsive documents from the Committee.
In letters to LimeWire and Streamcast, developers of popular “peer-to-peer” file sharing programs, Chairman Waxman and Ranking Member Davis requested information about potential privacy and security risks. Despite a voluntary pledge by several peer-to-peer companies to prevent the use of features that cause inadvertent file sharing, recent developments suggest that inadvertent file-sharing may still be a significant problem.
Chairman Waxman releases a report detailing the use of RNC political e-mail accounts by 88 White House officials. Senior advisor Karl Rove sent and received at least 140,216 e-mails on his RNC e-mail account, more than any other White House official, including over 75,000 e-mails communicating with individuals using official ”.gov” e-mail accounts. Deposition testimony from Susan Ralston, Mr. Rove’s former executive assistant, provides evidence that the White House Counsel’s office may have known in 2001 that Mr. Rove was using his RNC e-mail account for official correspondence but took no action to preserve these official communications.
In response to concerns raised by Chairman Waxman, the General Services Administration suspended a plan to hire contractors to conduct contract oversight and management.
In a letter to GSA Administrator Lurita Doan, Chairman Waxman asks for a briefing on GSA’s plans to expand the role of contractors into contract oversight and management. He also asks that GSA halt implementation of the proposal until Congress has a chance to conduct its oversight.
The Oversight Committee held a hearing on June 13, 2007, to examine statements made by GSA Administrator Lurita Doan that impugn the reputation of federal officials who cooperated with a Committee investigation into Ms. Doan’s conduct at the General Services Administration.
Rep. Waxman responds to Secretary Peters and reiterates his request for documents and an interview relating to the Department lobbying Members of Congress to oppose efforts by California and other states to reduce greenhouse gas emissions from motor vehicles.
In letters to Secretary of State Condoleezza Rice and former CIA Director George Tenet, Chairman Waxman explains that the previously scheduled hearing on the White House’s use of pre-war intelligence regarding Iraq’s nuclear program has been postponed while the Committee continues to interview senior government officials and review documents being provided by the CIA and State Department.
The Oversight Committee held a business meeting to consider the Carbon-Neutral Government Act (H.R. 2635), which is designed to reduce the emissions of the federal government, currently the largest energy consumer in the United States.
On June 7, 2007, Chairman Waxman introduced the Carbon-Neutral Government Act, H.R. 2635, which would promote federal leadership in the fight against global warming by making the federal government’s operations carbon-neutral by 2050.
In a letter to Mark Mactas the CEO of Towers Perrin, Chairman Waxman asks Towers Perrin to reconsider its refusal to cooperate with the Committee’s inquiry into potential conflicts of interest relating to the advice consultants provide to corporate boards on executive compensation.
Following a Committee hearing assessing the risks of the diabetes drug Avandia, the FDA announced the addition of two “black box” warnings on the drug label.
On June 6, 2007, the Committee held an oversight hearing on the role of the Food and Drug Administration in evaluating the safety of Avandia, a diabetes drug taken by about one million Americans. At the hearing, the Committee examined the failure of FDA to obtain an adequate post-market clinical trial designed to assess whether patients taking Avandia are at increased risk of heart attack.
Displaying Items 426 to 450 of 1458:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55] • [56] • [57] • [58] • [59]